Literature DB >> 22898188

Alternative peptide repertoire of HLA-E reveals a binding motif that is strikingly similar to HLA-A2.

Margit H Lampen1, Chopie Hassan, Marjolein Sluijter, Annemieke Geluk, Karin Dijkman, Jennifer M Tjon, Arnoud H de Ru, Sjoerd H van der Burg, Peter A van Veelen, Thorbald van Hall.   

Abstract

The non-classical HLA-E is a conserved class I molecule that mainly presents monomorphic leader peptides derived from other HLA class I molecules. These leader peptides comprise an optimized sequence for tight and deep binding into the HLA-E groove. In a TAP-deficient environment, as it can be generated during viral infection or in tumor tissue, loading of the classical leader peptide sequences is hampered leading to an alternative HLA-E peptide repertoire. In this study, we characterized this alternative peptide repertoire using cells in which TAP activity is inhibited. We identified more than 500 unique peptide sequences carried by HLA-E and found that their binding motif is different from the dominant leader peptides. Hydrophobic amino acids were only found at positions 2 and 9, in close resemblance to the peptide binding motif of HLA-A*0201. HLA-E-eluted peptides were indeed able to bind this classical HLA class I molecule. Our findings suggest that the dominant leader peptides uniquely conform to HLA-E, but that in their absence a peptide pool is presented like that of HLA-A*0201.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22898188     DOI: 10.1016/j.molimm.2012.07.009

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  41 in total

1.  MHC-E-Restricted CD8+ T Cells Target Hepatitis B Virus-Infected Human Hepatocytes.

Authors:  Benjamin J Burwitz; Patrick K Hashiguchi; Mandana Mansouri; Christine Meyer; Roxanne M Gilbride; Sreya Biswas; Jennie L Womack; Jason S Reed; Helen L Wu; Michael K Axthelm; Scott G Hansen; Louis J Picker; Klaus Früh; Jonah B Sacha
Journal:  J Immunol       Date:  2020-03-11       Impact factor: 5.422

2.  Vaccine-Mediated Inhibition of the Transporter Associated with Antigen Processing Is Insufficient To Induce Major Histocompatibility Complex E-Restricted CD8+ T Cells in Nonhuman Primates.

Authors:  Shaheed A Abdulhaqq; Helen Wu; John B Schell; Katherine B Hammond; Jason S Reed; Alfred W Legasse; Michael K Axthelm; Byung S Park; Aravind Asokan; Klaus Früh; Scott G Hansen; Louis J Picker; Jonah B Sacha
Journal:  J Virol       Date:  2019-09-12       Impact factor: 5.103

3.  Identification of HLA-E Binding Mycobacterium tuberculosis-Derived Epitopes through Improved Prediction Models.

Authors:  Paula Ruibal; Kees L M C Franken; Krista E van Meijgaarden; Marjolein van Wolfswinkel; Ian Derksen; Ferenc A Scheeren; George M C Janssen; Peter A van Veelen; Charlotte Sarfas; Andrew D White; Sally A Sharpe; Fabrizio Palmieri; Linda Petrone; Delia Goletti; Thomas Abeel; Tom H M Ottenhoff; Simone A Joosten
Journal:  J Immunol       Date:  2022-09-12       Impact factor: 5.426

Review 4.  Antigen presentation by MHC-E: a putative target for vaccination?

Authors:  Linda Voogd; Paula Ruibal; Tom H M Ottenhoff; Simone A Joosten
Journal:  Trends Immunol       Date:  2022-03-31       Impact factor: 19.709

5.  Peptide Binding to HLA-E Molecules in Humans, Nonhuman Primates, and Mice Reveals Unique Binding Peptides but Remarkably Conserved Anchor Residues.

Authors:  Paula Ruibal; Kees L M C Franken; Krista E van Meijgaarden; Joeri J F van Loon; Dirk van der Steen; Mirjam H M Heemskerk; Tom H M Ottenhoff; Simone A Joosten
Journal:  J Immunol       Date:  2020-10-05       Impact factor: 5.422

Review 6.  Unusual antigen presentation offers new insight into HIV vaccine design.

Authors:  Andrew J McMichael; Louis J Picker
Journal:  Curr Opin Immunol       Date:  2017-05-12       Impact factor: 7.486

7.  HLA-E-restricted, Gag-specific CD8+ T cells can suppress HIV-1 infection, offering vaccine opportunities.

Authors:  Hongbing Yang; Margarida Rei; Simon Brackenridge; Elena Brenna; Hong Sun; Shaheed Abdulhaqq; Michael K P Liu; Weiwei Ma; Prathiba Kurupati; Xiaoning Xu; Vincenzo Cerundolo; Edward Jenkins; Simon J Davis; Jonah B Sacha; Klaus Früh; Louis J Picker; Persephone Borrow; Geraldine M Gillespie; Andrew J McMichael
Journal:  Sci Immunol       Date:  2021-03-25

8.  Synergistic inhibition of natural killer cells by the nonsignaling molecule CD94.

Authors:  Kuldeep S Cheent; Khaleel M Jamil; Sorcha Cassidy; Mengya Liu; Berenice Mbiribindi; Arend Mulder; Frans H J Claas; Marco A Purbhoo; Salim I Khakoo
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-30       Impact factor: 11.205

9.  Diversity of natural self-derived ligands presented by different HLA class I molecules in transporter antigen processing-deficient cells.

Authors:  Elena Lorente; Susana Infantes; Eilon Barnea; Ilan Beer; Alejandro Barriga; Noel García-Medel; Fátima Lasala; Mercedes Jiménez; Arie Admon; Daniel López
Journal:  PLoS One       Date:  2013-03-26       Impact factor: 3.240

10.  Broadly targeted CD8⁺ T cell responses restricted by major histocompatibility complex E.

Authors:  Scott G Hansen; Helen L Wu; Benjamin J Burwitz; Colette M Hughes; Katherine B Hammond; Abigail B Ventura; Jason S Reed; Roxanne M Gilbride; Emily Ainslie; David W Morrow; Julia C Ford; Andrea N Selseth; Reesab Pathak; Daniel Malouli; Alfred W Legasse; Michael K Axthelm; Jay A Nelson; Geraldine M Gillespie; Lucy C Walters; Simon Brackenridge; Hannah R Sharpe; César A López; Klaus Früh; Bette T Korber; Andrew J McMichael; S Gnanakaran; Jonah B Sacha; Louis J Picker
Journal:  Science       Date:  2016-01-21       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.